logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Associated Retinal Consultants

+12482882280
Source: Site record.
https://www.arcpc.org/locations/royal-oak

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

Associated Retinal Consultants, P.C. (ARC) offers the latest technology and state of the art care for the full range of medical and surgical retinal conditions. We combine the best equipment in the field with the expertise of our physicians and staff to provide the highest quality, compassionate care for our patients. Some of the most common conditions and diagnoses of our patients include age-related macular degeneration (AMD), central serous retinopathy, diabetic retinopathy, floaters and light flashes, macular pucker and macular hole, retinal tears and retinal detachment, retinal vein and retinal artery occlusions, retinopathy of prematurity, tumors of the eye, and uveitis.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Eye care center

Business Subcategory

Source: Google. Eye care center
Source: Google. Ophthalmologist
Source: Google. Optician
Source: Google. Optometrist
Source: Google. Surgical center
Source: Trial-derived.
10Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
3Active Trials
Source: Trial-derived.
6Completed Trials
Source: Trial-derived.
17Unique Conditions
Source: Trial-derived.
5Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Macular Edema (3)Source: Trial-derived. Wet Age-related Macular Degeneration (3)Source: Trial-derived. AMD (2)Source: Trial-derived. CNV (2)Source: Trial-derived. Diabetic Macular Edema (2)Source: Trial-derived. nAMD (2)Source: Trial-derived. Neovascular Age-related Macular Degeneration (2)Source: Trial-derived. wAMD (2)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Kodiak Sciences Inc (3)Source: Trial-derived. Chugai Pharmaceutical (2)Source: Trial-derived. REGENXBIO Inc. (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Fundus photography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravitreal injection

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Best-corrected visual acuity testing
Source: AI-inferred. Anterior chamber paracentesis (aqueous humor sampling)
Source: AI-inferred. Letter-chart visual acuity testing
Source: AI-inferred. Subretinal gene therapy delivery